Broad activist support for paclitaxel as second-line treatment for Kaposi's sarcoma.
D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D017239:Paclitaxel / Q000627:therapeutic use*; D012514:Sarcoma, Kaposi / Q000188:drug therapy* / Q000209:etiology
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel